A practical guide about biosimilar data for health care providers treating inflammatory diseases

por Markenson, Joseph, Alvarez, Daniel F, Jacobs, Ira, Kirchhoff, Carol
Publicado 2017

Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?

por Alvarez, Daniel F., Wolbink, Gertjan, Cronenberger, Carol, Orazem, John, Kay, Jonathan
Publicado 2020

Randomized, Open‐Label, Single‐Dose, Parallel‐Group Pharmacokinetic Study of PF‐06410293 (adalimumab‐afzb), an Adalimumab Biosimilar, by Subcutaneous Dosing Using a Prefilled Syrin...

por Cox, Donna S., Alvarez, Daniel F., Bock, Amy E., Cronenberger, Carol L.
Publicado 2021

Assessing the Immunogenicity of Biopharmaceuticals

por Pineda, Carlos, Castañeda Hernández, Gilberto, Jacobs, Ira A., Alvarez, Daniel F., Carini, Claudio
Publicado 2016

Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis

por Kay, Jonathan, Bock, Amy E, Rehman, Muhammad, Zhang, Wuyan, Zhang, Min, Iikuni, Noriko, Alvarez, Daniel F
Publicado 2022

A mechanistic pharmacokinetic model with drug and antidrug antibody interplay, and its application for assessing the impact of immunogenicity response on bioequivalence testing

por Liao, Kai H., Udata, Chandrasekhar, Yin, Donghua, Sewell, K. Lea, Kantaridis, Constantino, Alvarez, Daniel F., Meng, Xu
Publicado 2020

Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a...

por Fleischmann, Roy M, Alvarez, Daniel F, Bock, Amy E, Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke
Publicado 2021

Long-term efficacy, safety, and immunogenicity of the adalimumab biosimilar, PF-06410293, in patients with rheumatoid arthritis after switching from reference adalimumab (Humira®)...

por Fleischmann, Roy M., Alvarez, Daniel F., Bock, Amy E., Cronenberger, Carol, Vranic, Ivana, Zhang, Wuyan, Alten, Rieke
Publicado 2021